article thumbnail

Best strains and terpenes for ASD

The Cannigma

Based on limited existing evidence, the best strain of cannabis for autism is a high-CBD strain with limited THC, and a terpene profile that includes beta-caryophyllene, linalool, limonene, pinene, or myrcene. Emerging data suggest ASD rates may be more similar in both sexes, but are less likely to be noticed in females.

article thumbnail

Athletes say this CBDA topical can make bruises fade overnight

The Cannigma

And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains. That’s why Kriva is recruiting 150 Cannigma readers to try the Daily Wellness Body Lotion and report back on their experiences over a 4-week data collection period.

Topical 82
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What are cannabis chemovars and chemotypes?

The Cannigma

Chemovars: Types of cannabis which are loosely defined and grouped, based on at least one or two of the most abundant cannabinoids and two-to-four main terpenes. What actually determines that effect is the chemovar aspect of the label (cannabinoids and terpenes and their quantities) and not the name of the product.

Terpenes 138
article thumbnail

What is CBD? Everything you need to know

The Cannigma

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122
article thumbnail

Marijuana & COVID-19: Top Studies [August 2020]

CannaMD

Terpenes and CBD: Twice as Effective. In April 2020, top Israeli cannabis research and development firms, Eybna and CannaSoul , collaborated to customize Ebyna’s NT-VRL terpene formulation to “optimize its anti-inflammatory and anti-viral properties.” Our initial data suggest that some C.

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Fig 1: Sucralose (In Study).